# Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease

> **NCT00677534** · NA · COMPLETED · sponsor: **University of Kansas** · enrollment: 7 (actual)

## Conditions studied

- End-Stage Renal Disease

## Interventions

- **DRUG:** Cholecalciferol

## Key facts

- **NCT ID:** NCT00677534
- **Lead sponsor:** University of Kansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677534, "Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00677534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*